Methyl bromide has been widely used as a fumigant in plant quarantine and agriculture, because of its strong insecticidal effect.1) However, methyl bromide is known to impair the function of the central nervous system (CNS) , when workers are exposed to it through inhalation and dermal contact. Disorders of the initiation and maintenance of sleep and wakefulness such as insomnia, somnolence, drowsiness and inebriation are observed in patients with methyl bromide intoxication, in addition to the main clinical symptoms such as vertigo, headache and unsteady gait.2-5) Recent studies with experimental animals have shown that methyl bromide induces changes in spontaneous locomotor activity,6,7) conditioned taste aversion,8) and brain levels of monoamines, acetylcholine and free amino acids9.10) as well as haematological and hepatological changes.11,12) In an attempt to clarify the acute effects of methyl bromide on the CNS, we investigated abnormal electrocorticographic activity and changes in sleep-wakefulness and its circadian rhythms after a single subcutaneous injection of methyl bromide in rats. The effects of possible hydrolysed products of methyl bromide, methanol and bromine ions on sleep and its rhythms were also examined.
administration. In order to examine the effect of hydrolysed products of methyl bromide, 5 rats were administered subcutaneously with sodium bromide/distilled water solution and methanol/distilled water solution. The dose levels of the two solutions were 49 mg NaBr/kg and 15 mg CH3OH/kg body weight. These levels were the same molar concentrations as 45 mg methyl bromide/kg. Polygraphic recordings were made on Days 1 and 3 after the injections of distilled water in order to obtain control values, and subsequently on Days 1 and 3 after each administration of NaBr solution and CH3OH solution. All injections were performed at 0800 h. Body weights of the rats ranged from 320 to 380 g at the time of the vehicle injection. Figure 1 shows the diurnal variations in the bihourly amounts of time spent by W, NREMS and REMS after the vehicle injection and subsequent administration of methyl bromide at doses of 45 and 15 mg/kg. The 45 mg/kg administration tended to decrease the bihourly amounts of NREMS and REMS at the expense of the increased W during the light period on Day 1. However, the bihourly amounts of NREMS and REMS increased at the expense of the decreased W during the dark period on the same day. On Day 3, light-phase amounts of NREMS and REMS returned to the control values. However, the bihourly amounts of NREMS and REMS during the dark period tended to increase in comparison to the control values, although there was no statistical difference between these two groups. Both NREM and REMS returned to normal on Day 5. The 15 mg/kg administration also produced a small but significant decrease in the bihourly amounts of NREMS and REMS during the first 4 hr of the light period on Day 1. The bihourly amounts of NREMS and REMS increased at the expense of the decreased W during the dark period. The bihourly amounts of W, NREMS and REMS recovered to the control values on Day 3. Power spectral analysis of the cortical EEG activities indicated that no significant alterations in the power spectral profiles up to 14 Hz were observed except for those of NREMS stage in which the power spectral density at 0.5-4 Hz tended to decrease after 45 mg/kg administration. As can be seen in Fig. 1 , the circadian rhythmicity of REMS was unequivocally altered, especially on Day 1 after both 15 and 45 mg/kg administrations. The acrophase of the circadian REMS rhythm in the methyl bromide-administered rats was delayed, as a result of initial suppression and subsequent facilitation of REMS occurrence. Table 1 shows the 12-hr amounts of W, NREMS and REMS after administration of sodium bromide solution or methanol solution. None of the 12-hr amounts of W, NREMS and REMS on Days 1 and 3 after injection of sodium bromide or methanol solution were statistically changed in comparison to the control values. It was found in the present study that the hydrolysed products of methyl bromide, bromine ions and methanol exerted little effect on the amounts of W, NREMS and REMS at the same molar dose as 45 mg methyl bromide/kg. Therefore, it may be tentatively concluded that the methyl bromide-induced changes in sleep-wakefulness and its circadian rhythms observed here are due not to the hydrolysed products of methyl bromide, bromine ions and methanol but to methyl bromide, itself. This conclusion is compatible with that presented by Irish et al.15) and Honma et al.7)
It was also found that amounts of W, NREMS and REMS were changed dose-dependently after a single injection of methyl bromide and that methyl bromide significantly disrupted the circadian REMS rhythm. Since methyl bromide possesses an irritant action on the eye, skin and throat,16) we cannot totally rule out the possibility that irritation by the subcutaneously-injected methyl bromide played a positive role in induction of the increased W observed immediately after the injection. Honma et al.7,9) reported that methyl bromide molecules are detected in the brain and contents of central monoamines and acetylcholine are changed after exposure of rats to methyl bromide vapor. Jouvet17) proposed a hypothesis that central neurons containing monoamines and acetylcholine regulate sleep-waking cycles. On the basis of the above findings,7,9,17) it may be inferred that the methyl bromide-induced changes in sleep and its rhythms observed in the present study are caused by interaction between methyl bromide molecules incorporated into the brain and certain CNS structures which are responsible for initiating and maintaining sleep-wakefulness and its cycles.
